Tideglusib
Product Specifications
UNSPSC Description
Tideglusib (NP031112) is an irreversible GSK-3 inhibitor with IC50s of 5 nM and 60 nM for GSK-3βWT (1 h preincubation) and GSK-3βC199A (1 h preincubation), respectively.
Target Antigen
GSK-3
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR;Stem Cell/Wnt
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Tideglusib.html
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
O=C(N(SC1=O)C2=C3C=CC=CC3=CC=C2)N1CC4=CC=CC=C4
Molecular Weight
334.39
References & Citations
[1]Domínguez JM, et al. Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib. J Biol Chem, 2012, 287(2), 893-90|[2]Luna-Medina R, et al. NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders. J Neurosci, 2007, 27(21), 5766-5776.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14872/Tideglusib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14872/Tideglusib-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
865854-05-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
sc-284725 250 mg
6-(2-Cyanoethylthio)-2'-deoxy-5'-O-DMT-N2-trifluoroacetylguanosine 3'-CE phosphoramidite
Ask
View Details MBS6168424-01 0.1 mL
BTBD9 (BTB (POZ) Domain Containing 9, FLJ32945, KIAA1880, MGC120517, MGC120519, MGC120520, dJ322I12.1) (APC)
Ask
View Details 
MBS6168424-02 5x 0.1 mL
BTBD9 (BTB (POZ) Domain Containing 9, FLJ32945, KIAA1880, MGC120517, MGC120519, MGC120520, dJ322I12.1) (APC)
Ask
View Details